| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hooks Corwin Dale | Chief Commercial Officer | C/O SPRUCE BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO | /s/ Samir Gharib, Attorney-in-Fact | 09 Mar 2026 | 0001665347 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SPRB | Restricted Stock Units | Award | +11,000 | $0.000000* | 11,000 | 09 Mar 2026 | Common Stock | 11,000 | $0.000000 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. |
| F2 | 25% of the total number of restricted stock units ("RSUs") will vest on March 15, 2027. 25% of the total number of RSUs will vest on each of March 15, 2028, March 15, 2029 and March 15, 2030, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. |